Moderna nearing deal with US government to develop Ebola vaccines — report
The biggest pandemic biotech darling is reportedly one step closer to securing a new deal for other serious infectious diseases.
Moderna is nearing an agreement with the US government to develop vaccines for Ebola and additional viruses considered to be threats, Bloomberg reported Wednesday. The deal is expected to see Moderna work with researchers from the University of Texas Medical Branch at Galveston to emulate its rapid approach to Covid-19 for such viruses.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.